Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TAM”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00893061
What this trial is testing

Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
Centre Oscar Lambret 44
Large-scale testing (Phase 3)Study completedNCT00036270
What this trial is testing

Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane

Who this might be right for
Breast Neoplasms
Pfizer 9,779
Large-scale testing (Phase 3)UnknownNCT00912548
What this trial is testing

Evaluating the Role of the Addition of Ovarian Function Suppression (OFS) to Tamoxifen in Young Women

Who this might be right for
Breast Cancer
Korean Breast Cancer Study Group 1,234
Testing effectiveness (Phase 2)Looking for participantsNCT06184750
What this trial is testing

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

Who this might be right for
Breast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Carcinoma+3 more
National Cancer Institute (NCI) 200
Testing effectiveness (Phase 2)UnknownNCT05669768
What this trial is testing

Study on the Efficacy and Toxicity of Pamiparib Combined With Tamoxifen in the Treatment of Epithelial Ovarian Cancer Patients With Biochemical Recurrence During First-line PARPi Maintenance Therapy

Who this might be right for
Ovarian Cancer
Sun Yat-sen University 46
Not applicableStudy completedNCT01896050
What this trial is testing

Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer

Who this might be right for
Breast CancerArthralgiaObesity
University of Michigan Rogel Cancer Center 115
Large-scale testing (Phase 3)Active Not RecruitingNCT01357772
What this trial is testing

Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up

Who this might be right for
Carcinoma, Intraductal, NoninfiltratingRecurrence, Local NeoplasmBreast Neoplasms+1 more
Andrea DeCensi 500
Large-scale testing (Phase 3)Ended earlyNCT00016341
What this trial is testing

Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer

Who this might be right for
Endometrial Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT04079517
What this trial is testing

Karolinska Interventional Study of Mammograhic Density (Karisma-1)

Who this might be right for
Breast CancerMammographic Density
Karolinska Institutet 42
Testing effectiveness (Phase 2)Study completedNCT02228681
What this trial is testing

Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer

Who this might be right for
Advanced, Persistent, or Recurrent Endometrial Cancer
GOG Foundation 74
Not applicableUnknownNCT05888701
What this trial is testing

"Don't Eat me" Signal in Hematological Malignancies: CD24 as New Target to Improve Anti-cancer Immunity.

Who this might be right for
Mantle-cell LymphomaB Cell Chronic Lymphocytic Leukemia
University of Milano Bicocca 30
Testing effectiveness (Phase 2)Study completedNCT06033092
What this trial is testing

Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion

Who this might be right for
BRCA MutationPALB2 Gene MutationDuctal Carcinoma in Situ+6 more
European Institute of Oncology 110
Very early researchStudy completedNCT00727948
What this trial is testing

The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy

Who this might be right for
Breast CancerAngiogenesis
University of Vermont 11
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07535905
What this trial is testing

Clinical Trial to Observe the Effects of Tamoxifen on Testosterone Recovery in Medically Castrated Prostate Cancer Patients

Who this might be right for
HypogonadismProstate Cancer
University Health Network, Toronto 96
Large-scale testing (Phase 3)Study completedNCT00066703
What this trial is testing

Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 2,672
Not applicableStudy completedNCT00784888
What this trial is testing

Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy

Who this might be right for
Breast Neoplasms
Pfizer 344
Testing effectiveness (Phase 2)Ended earlyNCT01194427
What this trial is testing

Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer

Who this might be right for
Stage I Breast CancerStage II Breast CancerStage III Breast Cancer+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2
Testing effectiveness (Phase 2)Study completedNCT00729586
What this trial is testing

Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer

Who this might be right for
Endometrial CarcinomaRecurrent Uterine Corpus CarcinomaStage IIIA Uterine Corpus Cancer+5 more
National Cancer Institute (NCI) 73
Not applicableStudy completedNCT01329224
What this trial is testing

The Antiaggregation Monitoring (TAM) Registry

Who this might be right for
Aspirin Causing Adverse Effects in Therapeutic Use
Stephane Cook 200
Testing effectiveness (Phase 2)Looking for participantsNCT04666961
What this trial is testing

Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ

Who this might be right for
Ductal Carcinoma in SituExtensive DiseaseMastectomy
Institut Cancerologie de l'Ouest 262
Next Page